BioNxt Solutions Inc. (OTCMKTS:BNXTF – Get Free Report) was the recipient of a large growth in short interest in May. As of May 29th, there was short interest totaling 101,894 shares, a growth of 119.6% from the May 14th total of 46,393 shares. Based on an average daily volume of 3,318 shares, the short-interest ratio is currently 30.7 days. Approximately 0.1% of the shares of the stock are short sold.
BioNxt Solutions Stock Performance
OTCMKTS BNXTF opened at $0.25 on Monday. The stock has a fifty day moving average of $0.33 and a 200-day moving average of $0.40. The stock has a market capitalization of $31.09 million, a P/E ratio of -5.08 and a beta of 0.64. BioNxt Solutions has a 52 week low of $0.14 and a 52 week high of $0.80.
BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) last released its earnings results on Friday, May 29th. The company reported ($0.01) EPS for the quarter.
About BioNxt Solutions
BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.
BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.
See Also
- Five stocks we like better than BioNxt Solutions
- 3 ETFs Giving Ready-Made Access to the Discounted International Small-Cap Space
- What to Expect From Q2 Earnings as Tech Strength Broadens
- Viasat’s Orbiting Profits: Space Force Jackpot?
- Robinhood Wants a Bigger Role in IPOs—Here’s Why It Matters
Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
